or
Results for disorders and  
Showing 11 - 20 of 2843
There is disclosed a method for diagnosing neurotransmission or developmental disorders in a mammal comprising the step of detecting in a bodily fluid of said mammal autoantibodies to an epitope of the muscle specific tyrosine kinase (MuSK). One such method comprises a) contacting said bodily fluid with said MuSK or an antigenic determinant thereof; and b) detecting any antibody-antigen complexes formed between said receptor tyrosine kinase or an antigenic fragment thereof and antibodies present...
The present invention relates to a method of treating chronic or non-chronic respiratory disorders, consisting in administering to the patient by the oral, rectal or parenteral route, a medicament for dilating the bronchi, comprising as active ingredient at least one compound of formula I or one of its pharmaceutically acceptable salts: ##STR1## in which A represents O or S, R.sub.1, R.sub.2, R.sub.3, R.sub.4 represent the hydrogen atom, an atom of halogen, an alkyl group with 1 to 4 carbon atom...
Pharmaceutical compositions containing a compound selected from 1-(3-trifluoromethyl phenyl)-2-(.beta.-hydroxyethyl)aminopropane and 1-(3-trifluoromethyl phenyl)-2-(.beta.-benzoyloxy ethyl)-aminopropane and physiologically acceptable acid addition salts thereof, useful in the treatment of metabolism disorders.
Use of .gamma.-linolenic acid and related materials alone or with zinc or .beta.-lactam antibiotics to treat menstrual disorders.
A diagnostic method for immune disorders comprising determining the immunoglobulin production or the DNA (deoxyribonucleic acid) synthesis of peripheral blood lymphocytes by stimulation with a new mitogen derived from either disintegrated microorganisms or culture fluid of microorganisms belonging to Staphylococcus.
The present invention relates to methods of treating chronic skin disorders by externally applying to the skin compounds by the following formula ##STR1## and therapeutically acceptable salts, esters and amides thereof, wherein R.sub.1 through R.sub.6 and X are as hereinafter defined.
Treating cerebrovascular disorders characterized by poor oxygenation with 3-[2-C benzamide-1-piperidyl) ethyl] indole.
Female disorders in animals are treated by electrically vibrating in the vagina of the animal a generally penis-shaped instrument having means for gradually releasing and distributing medications, such as hormone gels, antibiotics and the like during the vibration process. The instrument is provided with an elongated slot, preferably sinusoidal in character, containing or adapted to contain the medication desired. The vibrational energy penetrates well beyond the contacting surfaces of the vagin...
A pharmaceutical composition useful for the treatment of gastro-intestinal disorders comprising a diethylaminoethyl cross-linked dextran anion exchanger and a pharmaceutical carrier or another therapeutic agent and a method of treating gastro-intestinal disorders in mammals by the oral administration of such a composition.
Therapeutic process for treating panic disorders in humans comprising, the systemic administration of a 8-chloro-1-[(dimethylamino)-methyl]-6-phenyl-4H-s-triazolo[4,3-a][1,4]benz odiazepine including the N-oxides and pharmacologically acceptable acid addition salts thereof in combination with a pharmaceutical carrier.
1 2 3 4 5 6 7 8 9 10
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us